|
1
|
Liu X, Zhao W, Wang W, Lin S and Yang L:
Puerarin suppresses LPS-induced breast cancer cell migration,
invasion and adhesion by blockage NF-κB and Erk pathway. Biomed
Pharmacother. 92:429–436. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gan M and Yin X: Puerarin induced in
mantle cell lymphoma apoptosis and its possible mechanisms
involving multi-signaling pathway. Cell Biochem Biophys.
71:367–373. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Adlakha YK and Saini N: miR-128 exerts
pro-apoptotic effect in a p53 transcription-dependent and
-independent manner via PUMA-Bak axis. Cell Death Dis. 4:e5422013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ye Y, Zhuang J, Wang G, He S, Ni J and Xia
W: MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid
carcinoma progression. Oncol Lett. 14:7799–7806. 2017.PubMed/NCBI
|
|
5
|
Wang H, Li XT, Wu C, Wu ZW, Li YY, Yang
TQ, Chen GL, Xie XS, Huang YL, Du ZW and Zhou YX: miR-132 can
inhibit glioma cells invasion and migration by target MMP16 in
vitro. Onco Targets Ther. 8:3211–3218. 2015.PubMed/NCBI
|
|
6
|
Li JZ, Wang ZL, Xu WH, Li Q, Gao L and
Wang ZM: MicroRNA-495 regulates migration and invasion in prostate
cancer cells via targeting Akt and mTOR signaling. Cancer Invest.
34:181–188. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yao C, Shi X, Zhang Z, Zhou S, Qian T,
Wang Y, Ding F, Gu X and Yu B: Hypoxia-induced upregulation of
miR-132 promotes Schwann cell migration after sciatic nerve injury
by targeting PRKAG3. Mol Neurobiol. 53:5129–5139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leinders M, Üçeyler N, Pritchard RA,
Sommer C and Sorkin LS: Increased miR-132-3p expression is
associated with chronic neuropathic pain. Exp Neurol. 283:276–286.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu Q, Zhang M, Tu J, Pang L, Cai W and Liu
X: MicroRNA-122 affects cell aggressiveness and apoptosis by
targeting PKM2 in human hepatocellular carcinoma. Oncol Rep.
34:2054–2064. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Prasad NB, Kowalski J, Tsai HL, Talbot K,
Somervell H, Kouniavsky G, Wang Y, Dackiw AP, Westra WH, Clark DP,
et al: Three-gene molecular diagnostic model for thyroid cancer.
Thyroid. 22:275–284. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Imamura T, Komatsu S, Ichikawa D, Miyamae
M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Konishi H, Shiozaki
A, et al: Depleted tumor suppressor miR-107 in plasma relates to
tumor progression and is a novel therapeutic target in pancreatic
cancer. Sci Rep. 7:57082017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu T, Pang Q, Wang Y and Yan X: Betulinic
acid induces apoptosis by regulating PI3K/Akt signaling and
mitochondrial pathways in human cervical cancer cells. Int J Mol
Med. 40:1669–1678. 2017.PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lages E, Guttin A, El Atifi M, Ramus C,
Ipas H, Dupré I, Rolland D, Salon C, Godfraind C, de Fraipont F, et
al: MicroRNA and target protein patterns reveal physiopathological
features of glioma subtypes. PLoS One. 6:e206002011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eun JW, Kim HS, Shen Q, Yang HD, Kim SY,
Yoon JH, Park WS, Lee JY and Nam SW: MicroRNA-495-3p functions as a
tumour suppressor by regulating multiple epigenetic modifiers in
gastric carcinogenesis. J Pathol. 244:107–119. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oh K and Lee DS: In vivo validation of
metastasis-regulating microRNA-766 in human triple-negative breast
cancer cells. Lab Anim Res. 33:256–263. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jia B, Xia L and Cao F: The role of
miR-766-5p in cell migration and invasion in colorectal cancer. Exp
Ther Med. 15:2569–2574. 2018.PubMed/NCBI
|
|
18
|
Zaharieva ET, Kamenov ZA and Savov AS:
TLR4 polymorphisms seem not to be associated with prediabetes and
type 2 diabetes but predispose to diabetic retinopathy; TLR4
polymorphisms in glucose continuum. Endocr Regul. 51:137–144. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bahadori M, Baharara J and Amini E:
Anticancer properties of Chrysin on colon cancer cells, in vitro
and in vivo with modulation of caspase-3, −9, Bax and Sall4. Iran J
Biotechnol. 14:177–184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
LeBlanc H, Lawrence D, Varfolomeev E,
Totpal K, Morlan J, Schow P, Fong S, Schwall R, Sinicropi D and
Ashkenazi A: Tumor-cell resistance to death receptor-induced
apoptosis through mutational inactivation of the proapoptotic Bcl-2
homolog Bax. Nat Med. 8:274–281. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Chu ES, Chen HY, Man K, Go MY,
Huang XR, Lan HY, Sung JJ and Yu J: microRNA-29b prevents liver
fibrosis by attenuating hepatic stellate cell activation and
inducing apoptosis through targeting PI3K/AKT pathway. Oncotarget.
6:7325–7338. 2015.PubMed/NCBI
|
|
22
|
Yang SD, Ma L, Yang DL and Ding WY:
Combined effect of 17β-estradiol and resveratrol against apoptosis
induced by interleukin-1β in rat nucleus pulposus cells via
PI3K/Akt/caspase-3 pathway. PeerJ. 4:e16402016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Z, Shen J, Wu WK, Yu X, Liang J, Qiu G
and Liu J: Leptin induces cyclin D1 expression and proliferation of
human nucleus pulposus cells via JAK/STAT, PI3K/Akt and MEK/ERK
pathways. PLoS One. 7:e531762012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen HX, Xu XX, Tan BZ, Zhang Z and Zhou
XD: MicroRNA-29b inhibits angiogenesis by targeting VEGFA through
the MAPK/ERK and PI3K/Akt signaling pathways in endometrial
carcinoma. Cell Physiol Biochem. 41:933–946. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Q, Selth LA and Callen DF: MiR-766
induces p53 accumulation and G2/M arrest by directly targeting
MDM4. Oncotarget. 8:29914–29924. 2017.PubMed/NCBI
|
